UBS Group’s Viveon Health Acquisition Corp. VHAQ Stock Holding History
Bought
Maintained
Sold
Other funds holding VHAQ
MC
MSU
PC
CS
WCMNY
FTCM
BCM
CAC
UBS Group's VHAQ Position: Q3 2023 in Review
UBS Group sold out of Viveon Health Acquisition Corp. (VHAQ) in Q3 2023, closing a stake of 100 shares — an estimated $1.1K sold.
UBS Group first reported a position in VHAQ in Q1 2021 and held it in 7 quarters. The position peaked at $197K in Q4 2022. 8 funds tracked by Wall St. Rank hold VHAQ as of Q3 2023.
- UBS Group reported no remaining Viveon Health Acquisition Corp. position as of Q3 2023 after selling out during the quarter.
- UBS Group sold 100 Viveon Health Acquisition Corp. shares in Q3 2023, an estimated $1.1K.
- UBS Group first reported a position in Viveon Health Acquisition Corp. in Q1 2021 and held it in 7 quarters.
- UBS Group's Viveon Health Acquisition Corp. position peaked at $197K in Q4 2022.
- 8 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. as of Q3 2023.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.